EP3369435
Samsetning til meðferðar á bólgusjúkdómi í liðum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.7.2014EP published:
4.9.2019EP application number:
18167083.7
EP translation filed:
20.11.2019Grant published:
15.12.2019EPO information:
European Patent Register
Max expiry date:
16.7.2034Expiry date:
16.7.2024
Title:
COMPOSITION FOR THE TREATMENT OF INFLAMMATORY JOINT DISEASE
Timeline
Today
17.7.2014EP application
4.9.2019EP Publication
20.11.2019Translation submitted
15.12.2019Registration published
16.7.2024Expires
Owner
Name:
Xalud Therapeutics, Inc.Address:
2120 University Avenue, Suite 532, 94704, Berkeley, CA, US
Name:
The Regents of the University of Colorado, A Body CorporateAddress:
1800 Grant Street, 8th Floor, 80203, Denver, CO, US
Inventor
Name:
CHAVEZ, Raymond, A.Address:
Alameda, California, US
Name:
WATKINS, Linda, R.Address:
Boulder, Colorado, US
Name:
LANDRY, RobertAddress:
Erie, Colorado, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361847851 PDate:
18.7.2013Country:
US
Classification
Categories:
A61K 48/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 1.7.2020
Expires: 16.7.2021
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 1.7.2021
Expires: 16.7.2022
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 1.7.2022
Expires: 16.7.2023
Payer: Patice ehf.
Number: 10
Paid: 11.7.2023
Expires: 16.7.2024
Payer: Árnason Faktor ehf.